First published 10/1/2026, 9:08:15 PM · Last updated 10/1/2026, 9:08:15 PM

Quetiapine modestly improves sleep and breathing but impairs next-day performance in people with obstructive sleep apnea and difficulty maintaining sleep: a randomized controlled trial

A randomized controlled trial reports that quetiapine produced modest improvements in sleep and breathing but caused impaired next-day performance in people with obstructive sleep apnea who have difficulty maintaining sleep. The item is a journal article published by Oxford University Press on 2026-04-10.

Categories: public-health, science-and-space

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 6/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 5/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 2/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The trial identifies a trade-off between modest respiratory/sleep benefits and impaired next-day performance for this patient group.

Sources

Quetiapine modestly improves sleep and breathing but impairs next-day performance in people with obstructive sleep apnea and difficulty maintaining sleep: a randomized controlled trial

Report an issue